No Detail Found!

Kasabach-Merritt Syndrome: a case study of successful treatment with vincristine and propranolol

Author(s)
Aqsa Mazhar Vascular Anomalies Center, Indus Hospital and Health Network,Karachi,Pakistan
Afza Naureen Ghouse Department of Dermatology, Indus Hospital and Health Network, Karachi, Pakistan
Saba Shahid Department of Pediatric Medicine, Indus Hospital and Health Network,Karachi,Pakistan
Lubna Samad Interactive Research and Development (IRD),Global, Pakistan
Abstract
Kasabach-Merritt syndrome is a rare condition, characterised by the presence of an enlarging vascular tumour associated with thrombocytopenia, microangiopathic haemolytic anaemia and consumptive coagulopathy. The syndrome manifests in infancy, with high morbidity and mortality rates. No standard guidelines have been established for the treatment of Kasabach-Merritt syndrome to date. To existing literature we add this report of a four-month-old female child with Kasabach-Merritt syndrome who was successfully treated with propranolol and vincristine. This drug combination helped reverse the severe thrombocytopenia as well as decrease in size of her haemangioma. Management of Kasabach-Merritt syndrome continues to be a challenge, with varying response to first line drugs. Early diagnosis and initiation of treatment in a closely monitored setting is essential to ensure good outcomes. Since this is a relatively rare condition and large studies are not feasible, documenting treatment experience of single case or small series becomes even more important.
Publication Details
Page(s) 2476-2479
Published Journal: Journal of Pakistan Medical Association, Volume: 73, Issue: 12, Year: 2023

Request the full text from PASTIC

Keywords
Thrombocytopenia, Haemangioma, Kasabach-Merritt syndrome
0

Citations

0

Downloads

130

Views